Clinical Trials Directory

Trials / Unknown

UnknownNCT03578835

Bloodstream Infection Due to Multidrug-Resistant Organisms - Multicenter Study on Determinants of Clinical Outcomes

Status
Unknown
Phase
Study type
Observational
Enrollment
6,000 (estimated)
Sponsor
University Hospital Tuebingen · Academic / Other
Sex
All
Age
18 Years
Healthy volunteers
Not accepted

Summary

Continual surveillance of both community-acquired and nosocomial bloodstream infections for specific target organisms. Analysis of comorbidities, complications, bacterial resistance patterns, bacterial genomics (e. g. via WGS and MLST typing) for the determinants of clinical outcomes. The clinical outcomes are investigated both in the short-term (up until discharge) and the long-term (six months after index blood culture by standardized questionnaire). A predictive point-of-care score is to be developed based on these data to define high-risk patient populations requiring more intensive diagnostic and/or treatment regimens.

Conditions

Timeline

Start date
2017-02-01
Primary completion
2018-12-31
Completion
2019-06-30
First posted
2018-07-06
Last updated
2018-07-06

Locations

6 sites across 1 country: Germany

Source: ClinicalTrials.gov record NCT03578835. Inclusion in this directory is not an endorsement.